Issue 5/2012

The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma (475 — 485)

S. YIGIT, L. DEMIR, M. O. TARHAN, F. K. CABUK, H. ELLIDOKUZ, C. ERTEN, I. SOMALI, A. DIRICAN, F. CAKALAGAOGLU

DOI: 10.4149/neo_2012_061

SKLB1002, a novel inhibitor of VEGF receptor 2 signaling, induces vascular normalization to improve systemically administered chemotherapy efficacy (486 — 493)

G. SHEN, Y. LI, T. DU, G. SHI, L. DAI, X. CHEN, R. ZHENG, W. LI, X. SU, S. ZHANG, Y. WEI, S. YANG, H. DENG

DOI: 10.4149/neo_2012_062

Perioperative interstitial CT-based brachytherapy boost in breast cancer patients with breast conservation after neoadjuvant chemotherapy (494 — 499)

M. DOLEZEL, K. STASTNY, K. ODRAZKA, J. VANASEK, T. KOHLOVA, D. DVORAKOVA, I. KOLAROVA, T. KROULIK, L. JALCOVA

DOI: 10.4149/neo_2012_063

Biomarkers in the Lung Cancer Diagnosis: A Clinical Perspective (500 — 507)

X. LI, T. ASMITANANDA, L. GAO, D. GAI, Z. SONG, Y. ZHANG, H. REN, T. YANG, T. CHEN, M. CHEN

DOI: 10.4149/neo_2012_064

Epidermal growth factor receptor (EGFR) expression and mutations in the EGFR signaling pathway in correlation with anti-EGFR therapy in head and neck squamous cell carcinomas (508 — 515)

P. SMILEK, J. NEUWIRTHOVA, J. JARKOVSKY, L. DUSEK, J. ROTTENBERG, R. KOSTRICA, J. SROVNAL, M. HAJDUCH, J. DRABEK, J. KLOZAR

DOI: 10.4149/neo_2012_065

Immunohistochemical and histomorphological analysis of rat mammary tumors after simvastatin treatment (516 — 523)

P. KUBATKA, K. KAJO, K. ZIHLAVNIKOVA, K. ADAMICOVA, D. VYBOHOVA, M. PEC, V. NOSAL, N. STOLLAROVA, B. BOJKOVA, M. KASSAYOVA, P. ORENDAS

DOI: 10.4149/neo_2012_066

Mutational and expressional analyses of STAG2 gene in solid cancers (524 — 529)

M. S. KIM, S. S. KIM, E. M. JE, N. J. YOO, S. H. LEE,

DOI: 10.4149/neo_2012_067

Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome (530 — 535)

J. A. MACHADO-NETO, F. TRAINA, P. DE MELO CAMPOS, M. F. ANDREOLI-RISSO, F. F. COSTA, S. T. OLALLA SAAD

DOI: 10.4149/neo_2012_068

PET/CT significance for planning radiotherapy of head and neck cancer (536 — 540)

I. KOLAROVA, J. VANASEK, V. KANDRNAL, K. ODRAZKA, L. DUSEK, V. CHROBOK, O. BELOHLAVEK, M. DOLEZEL, L. PETRUZELKA, R. MICHALEK, J. JARKOVSKY

DOI: 10.4149/neo_2012_069

Knockdown of RhoGDIα induces apoptosis and increases lung cancer cell chemosensitivity to paclitaxel (541 — 550)

F. RONG, W. LI, K. CHEN, D. M. LI, W. M. DUAN, Y. Z. FENG, F. LI, X. W. ZHOU, S. J. FAN, Y. LIU, M. TAO

DOI: 10.4149/neo_2012_070

Tandem autologous stem cell transplantation in multiple myeloma after high-dose chemotherapy with two separate collections: single institution experience (551 — 558)

M. LADICKA, V. BALLOVA, L. DRGONA, A. VRANOVSKY, J. LAKOTA

DOI: 10.4149/neo_2012_071

Lung cancer in a Czech cohort exposed to radon in dwellings – 50 years of follow-up (559 — 565)

L. TOMASEK

DOI: 10.4149/neo_2012_072

The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer (566 — 573)

G. KELEMEN, V. FARKAS, J. DEBRAH, K. ORMANDI, A. VOROS, L. KAIZER, Z. VARGA, G. LAZAR, Z. KAHAN

DOI: 10.4149/neo_2012_073

COX-2 expression in fibroblast aggregates as a functional indicator for the anti-inflammatory activity of leukemia patients’ bone marrow-derived hematopoietic cells (574 — 583)

K. EGYUDOVA, M. FAJTOVA, A. CIZMAR, M. KORHONEN, J. GYARFAS, E. KANKURI, J. BIZIK

DOI: 10.4149/neo_2012_074

The intensity of internalization and cytotoxicity of superparamagnetic iron oxide nanoparticles with different surface modifications in human tumor and diploid lung cells (584 — 597)

M. MESAROSOVA, F. CIAMPOR, V. ZAVISOVA, M. KONERACKA, M. URSINYOVA, K. KOZICS, N. TOMASOVICOVA, A. HASHIM, I. VAVRA, Z. KRIZANOVA, Z. HUSEKOVA, M. KUBOVCIKOVA, P. KOPCANSKY, M. TIMKO, A. GABELOVA

DOI: 10.4149/neo_2012_075